introduction lung cancer leading cause cancer-related mortality worldwide accounting 18.4 total cancer death non-small cell lung cancer nsclc make case fall two major variation lung adenocarcinoma luad lung squamous cell carcinoma lusc comprise lung cancer respectively ability accurately project nsclc prognosis crucial inform physician decision-making remains difficult prediction task traditional approach tend use unimodal data source commonly clinical gene expression data predict survival however recent advance high throughput omics technology led publicly accessible description genetic epigenetic transcriptional profile cancer cell due high heterogeneity lung cancer cell integration multiple data type offer improved survival analysis unimodal approach providing context prediction although multimodal datasets provide potential build precise model lung cancer progression multimodal data integration technique still infancy many current multimodal approach predicting cancer progression geared toward pan-cancer prediction use deep learning processing data multimodal approach nsclc prediction specifically tend focus either identifying clinically meaningful subtypes patient predicting patient survival example lai implemented neural network combined gene expression clinical data predict 5-year nsclc survival another approach combined messenger rna mrna microrna mirna clinical data subtype luad patient performing survival analysis identifying survival-associated biological pathway emerging multimodal approach promising encounter common issue including effectively integrate heterogenous data modality early integration defined omics concatenation prior feature extraction allows modeling biological interaction different omics type modality processed together conversely late integration provides precise representation individual modality modality extracted separately relative effectiveness approach depends heavily prediction task amount data available however early integration commonly used due potential identify additional survival-related marker combining multiple omics type significant impediment multimodal approach remains high dimensionality sequencing data combined relatively small number patient causing model overfit solution include reducing dimensionality feature space using supervised unsupervised method previously used feature extraction algorithm include principal component analysis pca deep highway network autoencoders particular autoencoders fully connected neural network encoding decoding network path shown promise dimensionality reduction technique including application cancer datasets reducing data dimensionality bottleneck hidden layer decoding path bottleneck representation recreate original input minimizing chosen loss function autoencoders found improve accuracy predicting kidney cancer survival compared pca creating nonlinear feature combination despite demonstrated effective performance autoencoders highly prone overfitting recent survival prediction study experimented denoising autoencoders add excess noise input data improve generalization new data unsupervised method autoencoders sensitive feature relevant survival prediction problematic given relatively small subset genomic feature contributes survival prediction one solution implement use feature selection denoising autoencoder compression filter relevant feature study explored benefit multimodal data integration applied nsclc survival analysis included development robust early-integration patient survival model used combination feature selection denoising autoencoders dimensionality reduction using mrna mirna dna methylation long non-coding rna lncrna clinical data aimed demonstrate advantage combining multiple modality data predicting nsclc patient survival best knowledge combination modality particular lncrna modality multimodal context investigated nsclc survival prediction evaluated multiple data integration parameter estimation method well different autoencoder variation improve nsclc survival prediction identify predictive biomarkers associated patient survival result performance survival prediction multimodal setting predictive survival performance model using individual modality combination shown fig result averaged across independent test set evaluation see training evaluation approach section method multimodal model result reported using single denoising zero autoencoder early integration elastic net model trained luad lusc data result variation pipeline discussed method presented supplementary table figure figure predictive performance survival model based different modality including multimodal approach using independent test data luad lusc model using multimodal data integration demonstrate improved performance compared model using individual modality full size image performance model predicting luad patient survival superior lusc patient across individual modality multimodal setting agrees previous finding expected clinical data luad lusc strongly prognostic yet model based multimodal data outperformed model based clinical data alone individual omics modality specifically model utilizing early integrated multimodal data achieved mean c-indices 0.67 0.04 0.63 0.02 luad lusc data respectively compared c-indices 0.64 0.03 0.59 0.03 clinical data alone however difference statistically significant biological data seemed particularly informative luad modality except methylation achieved c-index least 0.60 contrast lusc data biological modality except lncrna scored average 0.55 c-index across nsclc subtypes methylation mirna showed lowest average performance appeared least predictive modality gene expression data moderately predictive performed best luad data scoring mean c-index 0.63 0.03 notably lncrna narrowly scored highest individual biological modality luad lusc data mean c-indices 0.64 0.03 0.56 0.02 respectively ultimately two-sample t-testing mean c-indices individual modality compared multimodal modality luad lusc revealed varied significance p-values 0.04 0.05 0.08 0.15 0.55 comparison mean c-index dna methylation mirna mrna lncrna clinical respectively multimodal evaluated combination modality well relationship modality examine among necessary strong survival performance supplementary table even combination two modality noticeably increased performance 2-omics luad combination except mirna clinical data outperformed every unimodal model fig lusc result similar except clinical data still one stronger predictor figure comparison model performance using 2-omic combination versus single modality top five highest-performing combination modality model evaluated independent test data using mean c-index full size image top five combination modality mean c-index shown fig notably combination lncrna clinical data achieved joint highest performance luad mean c-index 0.69 0.03 compared 0.67 0.03 modality lusc lncrna clinical data achieved mean c-index 0.62 0.03 second-highest result early integration modality relationship purely additive lncrna showed slightly higher performance mrna lncrna clinical data complemented well consistent previous observation five highest-performing lusc combination contained clinical data combination lncrna clinical data upon two-sample t-testing across nsclc type achieved p-values 0.03 0.03 0.05 compared mean c-indices dna methylation mirna mrna data respectively however p-value 0.11 found comparison combination clinical lncrna data unimodal lncrna p-value 0.48 comparing mean c-index unimodal clinical data although high-performing modality combination contained clinical data fig early integration biological modality input improved predictive power lusc luad supplementary table model using corresponding individual modality fact luad every early integration combination biological modality achieved equal better performance compared late integration strikingly early integration luad methylation mirna data resulted 0.09 increase mean c-index 0.57 0.02 0.66 0.03 compared late integration average performance also slightly higher lusc biological combination using early integration 0.013 mean difference however mean performance data combination included clinical data similar luad lusc regardless time integration supplementary table combination modality biomarker identification clustering analysis k-means clustering performed multimodal feature space using multimodal non-zero feature elastic net silhouette method used identify optimal cluster number largest average silhouette width appeared cluster kaplan–meier curve showed significant difference survival two group fig log-rank 1e-9 cluster better distinguished survival outcome nsclc type participating clustering process relatively even split luad lusc case cluster cluster luad case cluster luad case patient cluster exhibited consistently lower survival time explains slightly larger proportion lusc case gene commonly linked nsclc survival including egfr 0.002 log2 fold change log2fc 0.42 met 0.04 log2fc 0.29 erbb2 0.02 log2fc –0.23 differentially expressed cluster kras gene 0.17 log2fc 0.11 figure survival difference two group patient identified k-means clustering based multimodal feature space analysis full size image differential expression analysis used two group identify differentially expressed transcript among four biological modality cluster associated poorer survival identified differentially expressed gene upregulated downregulated differentially expressed lncrnas upregulated downregulated differentially expressed mirnas upregulated downregulated supplementary fig total gene differentially methylated cluster compared cluster gene displayed significantly higher mean methylation showed decreased methylation top five differentially expressed mrna mirnas lncrnas log2fc top five differentially methylated gene mean m-value difference across survival subtypes shown table downregulated gene cluster low albumin expression known poor survival indicator nsclc patient known solute carrier gene slc13a2 implicated cellular survival lung tumorigenesis additionally scgb1a1 determinant success nsclc radiation therapy immune checkpoint inhibitor combination therapy table top five differentially expressed transcript survival subtypes sorted largest absolute log2fc value absolute mean m-value difference methylation full size table lncrna greatest log2fc two group ervh48-1 used construct lusc prognostic signature seven lncrnas whereas linc01287 promotes proliferation prevents apoptosis luad cell previous research flj22447 found reprogram fibroblast promote growth oral squamous-cell carcinoma hsa-mir-34b hsa-mir-34c found significantly downregulated group agreement previous finding showing mirnas suppress luad tumor growth decreased expression conferred poorer survival upregulated mirna hsa-mir-891a recently identified novel biomarker nsclc study showing increased expression positively associated nsclc metastasis differentially methylated gene sept9 promoter hypermethylation evaluated marker early diagnosis lung cancer hypermethylation associated poor prognosis multiple cancer type furthermore one study methylation nomogram containing probe created luad prognosis prediction two probe located body fam125b gene cg12133048 cg13600632 exploratory analysis improve prediction patient survival comparison denoising autoencoder performance denoising zero autoencoder recorded highest mean survival performance sigmoid activation function addition zero matrix supplementary table parameter achieved average c-index 0.592 across modality greater next-highest value 0.590 latter achieved denoising gaussian autoencoder relu activation function 0.1 overall denoising zero autoencoder achieved slightly higher average survival performance achieving mean c-index 0.585 0.005 compared 0.582 0.005 denoising gaussian autoencoder 0.582 0.003 basic autoencoder varying training data examined whether training one nsclc data type improved survival performance increasing specificity prediction lusc performance improved training cancer type increase mean c-index 0.02 0.54 0.01 0.56 0.01 across modality supplementary table clinical methylation modality recorded mean c-index increase 0.05 whereas multimodal mirna data recorded mean c-index increase 0.04 improved performance lusc training conducted nsclc subtypes probably related noisy biological signal present lusc dataset well larger patient sample size training data type average c-index luad data increased 0.01 0.62 0.02 0.63 0.01 0.02 increase multimodal methylation modality otherwise performance appeared similar 0.02 decrease mirna modality supplementary table early vs. late data integration unclear whether early late multimodal integration genomic data lead better task performance analysis early late integration performed similarly luad dataset supplementary table lusc showed striking 0.04 increase mean c-index 0.59 0.03 0.63 0.02 early integration used case nonlinear combination lusc biological feature created autoencoder clearly predictive feature individual modality evaluation alternative dimensionality reduction scheme combination feature selection denoising autoencoder narrowly outperformed three alternative pipeline luad data early late integration supplementary fig lusc late integration combined approach predictive either feature selection denoising autoencoders individually yet early integration decisively favored proposed approach mean c-index 0.63 0.02 achieving highest overall lusc mean c-index although difference large combined approach achieved highest survival performance representing next-best methodology discussion result show modality integration improved prognosis prediction using multimodal data increased survival discrimination individual modality furthermore 2-omics combination outperformed almost unimodal approach nsclc type finding occurred despite increased feature space dimensionality modality combination demonstrating value proposed data integration methodology finding consistent previous liver cancer multimodal approach provide strong evidence potential multimodal data integration better describe heterogeneity nsclc patient model based combination clinical lncrna data achieved high performance luad lusc mean c-indices 0.69 0.03 0.62 0.03 respectively notably lncrnas included three four five top-performing modality combination lusc luad could partially explained low correlation lncrna modality although investigation lncrnas cancer relatively new lncrnas commonly dysregulated nsclc however exception one study used lncrnas clinical data establish nsclc risk score binary survival knowledge multimodal study examined predictive power lncrna modality luad lusc together study suggests predictive value modality significant overlap identified profile luad lusc research warranted validate finding overall highest survival performance achieved lncrna clinical data gene expression mirna clinical data luad mean c-index 0.69 0.03 using modality lusc mean c-index 0.63 0.02 challenging directly compare survival performance study difference performance evaluation method dataset utilized notable tcga lusc study implemented multimodal approach using basic autoencoders four biological data type achieve c-index 0.597 another study combined histopathology whole-slide image wsis clinical data 0.62 c-index examination previous tcga luad dataset performance one study used mrna data achieve c-index 0.656 second integrated mrna clinical data c-index 0.689 finally luad study used autoencoder combine mrna mirna methylation copy-number variation data achieve 0.65 c-index compared finding proposed methodology demonstrates comparable stronger performance using similar data provides biologically actionable result higher performance achieved cheerla gevaert potentially explained increase training data size using pan-cancer tcga data different cancer type line finding improved performance using luad lusc data training addition improved predictive power approach demonstrated multimodal analysis provides unique opportunity build robust survival subgroup take multiple aspect patient biology clinical status consideration differential analysis based survival subgroup identified combination differentially expressed mrna mirnas lncrnas well differentially methylated gene associated improved shortened survival top gene category previously linked shown associated nsclc and/or cancer prognosis see differential expression analysis section result several limitation placed data selection work include selection patient modality present could introduced bias patient population along line approach must validated additional external datasets multimodal datasets become publicly available future addition explore data modality proteomic copy-number variation wsi data could allow effective survival prediction lack interpretability autoencoders also major limitation study difficult determine extracted dimension reduced feature space represent method overview proposed data analysis approach summarized fig includes preprocessing step data cleaning supervised linear feature selection carried identify significant feature reduce dimensionality input data step performed biological modality separately modality integration single autoencoder used integrate compress biological data modality together 160-dimensional feature space adding clinical modality data brought dimensionality input data several type autoencoders evaluated improved survival performance demonstrated advantage denoising autoencoder survival analysis implemented elastic net model regularized cox proportional hazard model biomarker identification k-means clustering conducted survival-associated variable identified elastic net model multimodal feature space identify survival subtypes differential expression analysis carried survival subtypes identify biological transcript associated survival outcome figure proposed pipeline nsclc survival analysis full size image data data study obtained cancer genome atlas tcga dataset contains multiple modality lung cancer data including mirnas mrna expression data 44,162 gene dna methylation data 485,512 probe clinical data supplementary table addition 12,440 lncrnas extracted mrna modality according lncrna list published lin patient time-to-death day right-censored 11,000 day post-diagnosis binary survival status variable total nsclc patient sample five modality evaluated luad lusc subpopulation separately better understand difference generalizable commonality subpopulation patient 61.3 survived censored 38.7 died study period data modality combined 544,006 feature initial feature space clinical data used feature provided tcga table tumor volume variable calculated computing volume tumor using three dimension provided dataset table clinical feature included tcga dataset full size table preprocessing initial preprocessing step luad lusc datasets combined reported previously individual mrna mirna lncrna feature removed zero missing value patient dataset patient follow-up time day also removed feature modality z-scored i.e feature zero mean unit variance imputation performed missing value using median computation performed separately training testing data dna methylation feature tcga dataset consist beta value 485,512 probe ranging based methylation status probe missing value excluded remaining 395,616 probe addition 131,106 probe found cpg island within base pair upstream transcriptional start site used commonly used methylation processing approach finally top 25,000 probe highest beta value variance filtered extract informative feature led reduction lncrna feature 12,440 mrna feature 44,162 19,837 mirna feature methylation feature 485,512 25,000 fig linear feature selection prior autoencoder-based data integration lower dimensionality projection feature modality separately evaluated process ensure feature relevance prediction task specifically wald significance test based univariate cox model employed measure association feature patient survival time top feature mrna methylation top feature lncrna mirna lowest wald value selected modality proportional initial number feature modality feature selection performed using training data validation schema presented training evaluation approach section denoising autoencoder final nsclc pipeline employ single denoising zero autoencoder add noise input data randomly replacing percentage input matrix zero denoising zero autoencoder take concatenated biological data feature reduces data 160-dimensional vector supplementary fig choosing final autoencoder structure tested compared performance denoising zero autoencoder denoising autoencoder add zero-centered gaussian noise data chosen standard deviation distribution denoising gaussian autoencoder also compared performance basic autoencoder denoising function additional hyperparameters performance autoencoder model hyperparameter combination assessed averaging c-index across individual modality well multimodal modality supplementary table model employed adaptive moment estimation optimizer mean squared error loss function learning rate 0.001 balance accuracy training time combat overfitting autoencoders trained epoch early stopping mechanism ended training validation loss improve epoch denoising autoencoder type rectified linear unit relu tanh sigmoid activation function compared denoising zero autoencoder proportion matrix observation replaced zero modulated 0.2 0.3 0.4 distribution noise added 0.5 1.5 adjusted denoising gaussian model supervised survival modeling study used elastic net survival model model regularized form cox model deal effectively high-dimensional data preventing overfitting specifically elastic net lasso ridge regularization together penalize complex cox model decrease coefficient value alpha value determines much weight given penalty alpha value 0.5 chosen give equal weight training data used find optimal lambda value coefficient determines degree coefficient shrinkage integration different combination modality addition combining modality survival prediction model evaluated several two three four modality combination early late data integration evaluated combination survival clustering stratification differential expression analysis biomarker identification gain additional insight feature affecting patient survival implemented k-means clustering using feature significantly associated survival elastic net model using one training run feature coefficient driven zero elastic net model removed keep survival-associated feature survival-related feature used unsupervised k-means clustering identify distinct survival subtypes optimal number cluster determined silhouette index cluster evaluated using identified survival subtypes conducted differential expression analysis find difference mrna mirna lncrna expression group differential expression defined false-discovery rate adjusted value 0.05 absolute fold change 1.5 methylation data beta value mapped m-values logistic transformation methylation probe mapped gene averaging m-values across gene analysis-of-variance test identified differentially methylated gene based mean m-value described previously 0.05 training evaluation approach used robust training/validation independent test set schema reporting result training/validation data data used parameter estimation preprocessing modeling step result reported independent test set data ass stability result report confidence interval bootstrapping schema introduced result reported across independent run performance evaluation estimate prediction error used harrell concordance index c-index commonly used metric survival analysis c-index used evaluate probability model correctly predict two randomly selected patient die first word measure ability correctly order patient term survival time ranging 0.5 random chance perfect prediction exploratory analysis improve patient survival prediction varying training data earlier study showed improved performance survival model training using pan-cancer data however due prevalence luad lusc case tcga survival model may prioritize feature geared toward luad compromising lusc performance training done luad lusc therefore compared model performance trained using luad lusc data versus combination early vs. late data integration effect reducing data dimensionality data type separately late integration compared using one denoising autoencoder compress biological data 160-dimensional vector together early integration late integration autoencoder structured layer size mrna methylation data mirna lncrna data survival performance compared using c-index integration scheme multimodal data possible combination omics data comparison dimensionality reduction approach performance combined feature selection autoencoder feature reduction approach compared three alternative data dimensionality reduction method alternative denoising autoencoder feature selection pca autoencoder compared survival performance four technique multimodal data across nsclc type early late modality integration implementation data analysis study completed version 4.2.0 kera package tensorflow back end employed implement denoising autoencoders differential expression analysis implemented deseq2 package lumi package used map beta value m-values differential methylation analysis